Table 1. Relevance of BIRC5 expression and different clinicopathological features using the bc-GenExMiner database.
| Variables | Number of patients | BIRC5 mRNA | P-value |
|---|---|---|---|
| Age (years) | 0.1561 | ||
| ≤51 | 1392 | - | |
| >51 | 2210 | - | |
| ER | <0.0001 | ||
| Negative | 1559 | Increased | |
| Positive | 3988 | - | |
| PR | <0.0001 | ||
| Negative | 946 | Increased | |
| Positive | 1439 | - | |
| HER-2 | 0.0152 | ||
| Negative | 1409 | - | |
| Positive | 201 | Increased | |
| Nodal status | 0.2654 | ||
| Negative | 2493 | - | |
| Positive | 1562 | - | |
| Basal-like status | <0.0001 | ||
| Non-basal-like | 4200 | - | |
| Basal-like | 1144 | Increased | |
| Triple-negative status | <0.0001 | ||
| Non-triple-negative | 4099 | - | |
| Triple-negative | 374 | Increased |
Abbreviation: ER, estrogen receptor; PR, progesterone receptor.